

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.50737056 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 9.26440349 |
| 3 | * L-phenylalanine catabolic process (GO:0006559) | 7.46619752 |
| 4 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.46619752 |
| 5 | * L-phenylalanine metabolic process (GO:0006558) | 7.10268101 |
| 6 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.10268101 |
| 7 | * aromatic amino acid family catabolic process (GO:0009074) | 6.80512481 |
| 8 | drug metabolic process (GO:0017144) | 6.59435421 |
| 9 | oxidative demethylation (GO:0070989) | 6.38365346 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.29051957 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.29051957 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.29051957 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.25876767 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.11995121 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.99712057 |
| 16 | urea metabolic process (GO:0019627) | 5.91071896 |
| 17 | urea cycle (GO:0000050) | 5.91071896 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.90905568 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.73763312 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.60700805 |
| 21 | S-adenosylmethionine metabolic process (GO:0046500) | 5.59970637 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.57754509 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52504160 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.44469369 |
| 25 | ethanol metabolic process (GO:0006067) | 5.43610638 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.43370407 |
| 27 | cysteine metabolic process (GO:0006534) | 5.41603327 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.40836308 |
| 29 | regulation of fibrinolysis (GO:0051917) | 5.40573677 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.39356907 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38372170 |
| 32 | protein carboxylation (GO:0018214) | 5.38372170 |
| 33 | regulation of plasminogen activation (GO:0010755) | 5.37587042 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.22643640 |
| 35 | bile acid metabolic process (GO:0008206) | 5.12873735 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 5.07187583 |
| 37 | opsonization (GO:0008228) | 5.06395360 |
| 38 | regulation of complement activation (GO:0030449) | 5.05386261 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.98097231 |
| 40 | * aromatic amino acid family metabolic process (GO:0009072) | 4.88213329 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.85723127 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85034567 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.81848636 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.80387896 |
| 45 | acute-phase response (GO:0006953) | 4.77412801 |
| 46 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.74238691 |
| 47 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.74238691 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.73819266 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.73819266 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.73819266 |
| 51 | * alpha-amino acid catabolic process (GO:1901606) | 4.67703267 |
| 52 | regulation of humoral immune response (GO:0002920) | 4.67659172 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.64635141 |
| 54 | lysine metabolic process (GO:0006553) | 4.62331959 |
| 55 | lysine catabolic process (GO:0006554) | 4.62331959 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.61746419 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.61746419 |
| 58 | alkaloid metabolic process (GO:0009820) | 4.56367269 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.55006785 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.55006785 |
| 61 | negative regulation of blood coagulation (GO:0030195) | 4.52821571 |
| 62 | negative regulation of hemostasis (GO:1900047) | 4.52821571 |
| 63 | phospholipid efflux (GO:0033700) | 4.51477815 |
| 64 | glycine metabolic process (GO:0006544) | 4.46524333 |
| 65 | coenzyme catabolic process (GO:0009109) | 4.45908635 |
| 66 | negative regulation of protein activation cascade (GO:2000258) | 4.45648167 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.45004030 |
| 68 | bile acid and bile salt transport (GO:0015721) | 4.43580014 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.40874727 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 4.36642294 |
| 71 | amine catabolic process (GO:0009310) | 4.36642294 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 4.34468589 |
| 73 | flavonoid metabolic process (GO:0009812) | 4.33042261 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 4.31991444 |
| 75 | * tyrosine metabolic process (GO:0006570) | 4.29932712 |
| 76 | * cellular amino acid catabolic process (GO:0009063) | 4.29416921 |
| 77 | cellular glucuronidation (GO:0052695) | 4.26796405 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 4.23816835 |
| 79 | cholesterol efflux (GO:0033344) | 4.18488195 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.15193474 |
| 81 | arginine metabolic process (GO:0006525) | 4.14434639 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 4.10702756 |
| 83 | negative regulation of coagulation (GO:0050819) | 4.09875325 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.07481588 |
| 85 | ethanol oxidation (GO:0006069) | 4.06558365 |
| 86 | negative regulation of wound healing (GO:0061045) | 4.06038484 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 4.05651670 |
| 88 | * glutamate metabolic process (GO:0006536) | 4.03489504 |
| 89 | fibrinolysis (GO:0042730) | 4.02075751 |
| 90 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.00003010 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.99096160 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96896764 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 3.94734812 |
| 94 | drug catabolic process (GO:0042737) | 3.94564943 |
| 95 | intestinal cholesterol absorption (GO:0030299) | 3.90858608 |
| 96 | positive regulation of blood coagulation (GO:0030194) | 3.90681337 |
| 97 | positive regulation of hemostasis (GO:1900048) | 3.90681337 |
| 98 | heme transport (GO:0015886) | 3.85774447 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83527145 |
| 100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.82234670 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.82203578 |
| 102 | cofactor catabolic process (GO:0051187) | 3.82049837 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.78237069 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.78237069 |
| 105 | complement activation (GO:0006956) | 3.77891709 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.77786137 |
| 107 | ketone body metabolic process (GO:1902224) | 3.75949402 |
| 108 | phospholipid homeostasis (GO:0055091) | 3.75574035 |
| 109 | protein activation cascade (GO:0072376) | 3.74533067 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.74427635 |
| 111 | * organic acid catabolic process (GO:0016054) | 3.74323747 |
| 112 | * carboxylic acid catabolic process (GO:0046395) | 3.74323747 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73838766 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73838766 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 3.73252093 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72973814 |
| 117 | cytolysis (GO:0019835) | 3.72726161 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.71431426 |
| 119 | hormone catabolic process (GO:0042447) | 3.71038887 |
| 120 | sterol homeostasis (GO:0055092) | 3.68257682 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.67784897 |
| 122 | negative regulation of complement activation (GO:0045916) | 3.62253343 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 3.62190943 |
| 124 | xenobiotic metabolic process (GO:0006805) | 3.61066544 |
| 125 | plasma lipoprotein particle organization (GO:0071827) | 3.58583589 |
| 126 | positive regulation of coagulation (GO:0050820) | 3.58329537 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.57562261 |
| 128 | protein-lipid complex assembly (GO:0065005) | 3.53538376 |
| 129 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53536619 |
| 130 | acute inflammatory response (GO:0002526) | 3.53326457 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.45081816 |
| 132 | regulation of apoptotic cell clearance (GO:2000425) | 3.39057221 |
| 133 | exogenous drug catabolic process (GO:0042738) | 10.2373254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.43317990 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20370511 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.00210596 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52097014 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.41281581 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17997853 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78614254 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06414063 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03798660 |
| 10 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06023774 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0112665 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97456072 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96575765 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60734206 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57184613 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55910345 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45795965 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40472500 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28068138 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25027775 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19783753 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17518324 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08601103 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07708760 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01513690 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01286538 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95438767 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95348875 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93371487 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92964848 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92439156 |
| 32 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.90826103 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90170305 |
| 34 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89028903 |
| 35 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88529510 |
| 36 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88228683 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86616198 |
| 38 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.85649509 |
| 39 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84597743 |
| 40 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84255391 |
| 41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84131421 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81256884 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.81220082 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80467804 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.79863388 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79843809 |
| 47 | NFYA_21822215_ChIP-Seq_K562_Human | 0.79841827 |
| 48 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79789829 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79600584 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79297098 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77993673 |
| 52 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77003748 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76476322 |
| 54 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76292861 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75704100 |
| 56 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.75318721 |
| 57 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74763502 |
| 58 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74709000 |
| 59 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73404101 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71887223 |
| 61 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71839397 |
| 62 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71680491 |
| 63 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.71297020 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70900345 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.70237808 |
| 66 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70104061 |
| 67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.69480948 |
| 68 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.69480948 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69063201 |
| 70 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.68070335 |
| 71 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.68052047 |
| 72 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.67035454 |
| 73 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.66479805 |
| 74 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66367316 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.65720898 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65680891 |
| 77 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.65420623 |
| 78 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.64810448 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64610990 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.64517667 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64127736 |
| 82 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64021102 |
| 83 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.63135995 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63061801 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63061801 |
| 86 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.62848328 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.62516977 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.62174175 |
| 89 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.62069011 |
| 90 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.61887666 |
| 91 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61727130 |
| 92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61101169 |
| 93 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.61077300 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60982891 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60015624 |
| 96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59541069 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.58604963 |
| 98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.58604963 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 0.57474602 |
| 100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.57422359 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.56121228 |
| 102 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.55796608 |
| 103 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.55738084 |
| 104 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55695900 |
| 105 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.55560489 |
| 106 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.55293625 |
| 107 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54121067 |
| 108 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53995507 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53029400 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52829801 |
| 111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52540214 |
| 112 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51655964 |
| 113 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51540753 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51524852 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51278272 |
| 116 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50026362 |
| 117 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48212922 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48040253 |
| 119 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46921438 |
| 120 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46525841 |
| 121 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46309170 |
| 122 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46186193 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45532523 |
| 124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43848696 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43835917 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.43298647 |
| 127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42339129 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42237492 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41162959 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40674690 |
| 131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40339409 |
| 132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39699394 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39277376 |
| 134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39190246 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38454617 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38228266 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37757088 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37732426 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37394016 |
| 140 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36815426 |
| 141 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35736634 |
| 142 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35297749 |
| 143 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34675395 |
| 144 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34583020 |
| 145 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.34575001 |
| 146 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34007852 |
| 147 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.33974750 |
| 148 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.33761500 |
| 149 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.33540654 |
| 150 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33454195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25776723 |
| 2 | MP0005360_urolithiasis | 7.55168787 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.51611676 |
| 4 | MP0005365_abnormal_bile_salt | 6.19329668 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18246286 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26219221 |
| 7 | MP0003252_abnormal_bile_duct | 3.93862751 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57107826 |
| 9 | MP0009840_abnormal_foam_cell | 3.30102746 |
| 10 | MP0005083_abnormal_biliary_tract | 3.02429984 |
| 11 | MP0003195_calcinosis | 2.86642315 |
| 12 | MP0005332_abnormal_amino_acid | 2.80125211 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59751966 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.30408017 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17341474 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.14665585 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10679140 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00113994 |
| 19 | MP0003868_abnormal_feces_composition | 1.97749388 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83849826 |
| 21 | MP0001764_abnormal_homeostasis | 1.68844955 |
| 22 | MP0009697_abnormal_copulation | 1.58455927 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56418894 |
| 24 | MP0005451_abnormal_body_composition | 1.44158234 |
| 25 | MP0003011_delayed_dark_adaptation | 1.36620525 |
| 26 | MP0003186_abnormal_redox_activity | 1.26622867 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.23596267 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.23177482 |
| 29 | MP0000598_abnormal_liver_morphology | 1.18969571 |
| 30 | MP0003879_abnormal_hair_cell | 1.17269550 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.15535359 |
| 32 | MP0005647_abnormal_sex_gland | 1.12614526 |
| 33 | MP0000604_amyloidosis | 1.05623924 |
| 34 | MP0009764_decreased_sensitivity_to | 1.04647518 |
| 35 | MP0009763_increased_sensitivity_to | 1.02395871 |
| 36 | MP0002132_abnormal_respiratory_system | 1.01816564 |
| 37 | MP0002254_reproductive_system_inflammat | 1.01409839 |
| 38 | MP0005670_abnormal_white_adipose | 0.97497539 |
| 39 | MP0010368_abnormal_lymphatic_system | 0.90944279 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.90850565 |
| 41 | MP0008469_abnormal_protein_level | 0.88534342 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.87025219 |
| 43 | MP0005408_hypopigmentation | 0.85265312 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 0.80955998 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.79991752 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.79216273 |
| 47 | MP0002282_abnormal_trachea_morphology | 0.78420296 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.78318375 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.76435684 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 0.74315301 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 0.74114459 |
| 52 | MP0002971_abnormal_brown_adipose | 0.73533563 |
| 53 | MP0005334_abnormal_fat_pad | 0.69553644 |
| 54 | MP0001661_extended_life_span | 0.69177925 |
| 55 | MP0004130_abnormal_muscle_cell | 0.68247424 |
| 56 | MP0003690_abnormal_glial_cell | 0.66948819 |
| 57 | MP0005535_abnormal_body_temperature | 0.66884251 |
| 58 | MP0005266_abnormal_metabolism | 0.65586848 |
| 59 | MP0009053_abnormal_anal_canal | 0.64528341 |
| 60 | MP0003646_muscle_fatigue | 0.63897838 |
| 61 | MP0001915_intracranial_hemorrhage | 0.62089344 |
| 62 | MP0003329_amyloid_beta_deposits | 0.62013399 |
| 63 | MP0005187_abnormal_penis_morphology | 0.61818542 |
| 64 | MP0001756_abnormal_urination | 0.60044167 |
| 65 | MP0002249_abnormal_larynx_morphology | 0.59652251 |
| 66 | MP0000639_abnormal_adrenal_gland | 0.59472368 |
| 67 | MP0003136_yellow_coat_color | 0.57539057 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.56718400 |
| 69 | MP0005448_abnormal_energy_balance | 0.54985692 |
| 70 | MP0003045_fibrosis | 0.52560969 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.51483055 |
| 72 | MP0005395_other_phenotype | 0.49879819 |
| 73 | MP0003718_maternal_effect | 0.49282718 |
| 74 | MP0002822_catalepsy | 0.48349442 |
| 75 | MP0009785_altered_susceptibility_to | 0.47242119 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.45996140 |
| 77 | MP0008873_increased_physiological_sensi | 0.45710139 |
| 78 | MP0008874_decreased_physiological_sensi | 0.45373853 |
| 79 | MP0002928_abnormal_bile_duct | 0.45019721 |
| 80 | MP0002653_abnormal_ependyma_morphology | 0.44017840 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.43990875 |
| 82 | MP0003436_decreased_susceptibility_to | 0.42929499 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.42681597 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.42042158 |
| 85 | MP0003724_increased_susceptibility_to | 0.41428317 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.41352627 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.41207996 |
| 88 | MP0004381_abnormal_hair_follicle | 0.40607658 |
| 89 | MP0003953_abnormal_hormone_level | 0.40565703 |
| 90 | MP0005248_abnormal_Harderian_gland | 0.40144583 |
| 91 | MP0003075_altered_response_to | 0.38294473 |
| 92 | MP0005171_absent_coat_pigmentation | 0.37791865 |
| 93 | MP0000579_abnormal_nail_morphology | 0.37714309 |
| 94 | MP0009672_abnormal_birth_weight | 0.37573962 |
| 95 | MP0005166_decreased_susceptibility_to | 0.37316513 |
| 96 | MP0008872_abnormal_physiological_respon | 0.36568582 |
| 97 | MP0003890_abnormal_embryonic-extraembry | 0.35026255 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.33951804 |
| 99 | MP0009115_abnormal_fat_cell | 0.32710701 |
| 100 | MP0002796_impaired_skin_barrier | 0.32169605 |
| 101 | MP0001243_abnormal_dermal_layer | 0.32127664 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.31582266 |
| 103 | MP0002970_abnormal_white_adipose | 0.31567996 |
| 104 | MP0002168_other_aberrant_phenotype | 0.31092611 |
| 105 | MP0005023_abnormal_wound_healing | 0.30915365 |
| 106 | MP0000249_abnormal_blood_vessel | 0.30903375 |
| 107 | MP0001853_heart_inflammation | 0.30075621 |
| 108 | MP0004883_abnormal_blood_vessel | 0.29199320 |
| 109 | MP0001881_abnormal_mammary_gland | 0.28888488 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.27843755 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.27309821 |
| 112 | MP0006082_CNS_inflammation | 0.27223079 |
| 113 | MP0000566_synostosis | 0.26563323 |
| 114 | MP0004142_abnormal_muscle_tone | 0.25975276 |
| 115 | MP0002090_abnormal_vision | 0.25414745 |
| 116 | MP0002060_abnormal_skin_morphology | 0.25255537 |
| 117 | MP0005164_abnormal_response_to | 0.23523800 |
| 118 | MP0000427_abnormal_hair_cycle | 0.23505103 |
| 119 | MP0000467_abnormal_esophagus_morphology | 0.23110535 |
| 120 | MP0003878_abnormal_ear_physiology | 0.21812687 |
| 121 | MP0005377_hearing/vestibular/ear_phenot | 0.21812687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.43634251 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.32917586 |
| 3 | * Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.05849501 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.60673570 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.49590403 |
| 6 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.47895103 |
| 7 | Xanthomatosis (HP:0000991) | 6.34946888 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.67778673 |
| 9 | Complement deficiency (HP:0004431) | 5.50164123 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.82934488 |
| 11 | Joint hemorrhage (HP:0005261) | 4.77278775 |
| 12 | Hyperammonemia (HP:0001987) | 4.67888074 |
| 13 | Epidermoid cyst (HP:0200040) | 4.63028005 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.48840297 |
| 15 | Hyperglycinemia (HP:0002154) | 4.45395956 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.44742877 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42893557 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.36271714 |
| 19 | Ketosis (HP:0001946) | 4.26771393 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.26334687 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.24135080 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.21076841 |
| 23 | Fat malabsorption (HP:0002630) | 4.11797846 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.01588486 |
| 25 | Abnormality of complement system (HP:0005339) | 4.00961696 |
| 26 | Hyperglycinuria (HP:0003108) | 3.92197545 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.91348820 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.91348820 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.84761123 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.78887974 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78197184 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.63865922 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36860152 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.32746350 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30483782 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 3.14753113 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.12461196 |
| 38 | Steatorrhea (HP:0002570) | 3.09989672 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.07792196 |
| 40 | Spontaneous abortion (HP:0005268) | 3.07157678 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 3.00420600 |
| 42 | Ketoacidosis (HP:0001993) | 2.98876904 |
| 43 | Myocardial infarction (HP:0001658) | 2.97819137 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.92036883 |
| 45 | Skin nodule (HP:0200036) | 2.88082126 |
| 46 | Neonatal hypoglycemia (HP:0001998) | 2.77660674 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.75823092 |
| 48 | Fair hair (HP:0002286) | 2.74391183 |
| 49 | Metabolic acidosis (HP:0001942) | 2.74299368 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.67897551 |
| 51 | Lethargy (HP:0001254) | 2.63610772 |
| 52 | Purpura (HP:0000979) | 2.58930407 |
| 53 | Vascular calcification (HP:0004934) | 2.55263071 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.54185422 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54185422 |
| 56 | Acanthocytosis (HP:0001927) | 2.53741755 |
| 57 | Gout (HP:0001997) | 2.53140680 |
| 58 | Spastic diplegia (HP:0001264) | 2.48966914 |
| 59 | Glomerulonephritis (HP:0000099) | 2.48274101 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.47974015 |
| 61 | Cerebral edema (HP:0002181) | 2.47808210 |
| 62 | Pulmonary embolism (HP:0002204) | 2.46430062 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.46427692 |
| 64 | Mitral stenosis (HP:0001718) | 2.44360585 |
| 65 | Irritability (HP:0000737) | 2.42816187 |
| 66 | Osteomalacia (HP:0002749) | 2.38947124 |
| 67 | Cholelithiasis (HP:0001081) | 2.38899167 |
| 68 | Neonatal onset (HP:0003623) | 2.38608744 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38487019 |
| 70 | Cholecystitis (HP:0001082) | 2.34459012 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.34459012 |
| 72 | Amyloidosis (HP:0011034) | 2.29394431 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.26016269 |
| 74 | Gingival bleeding (HP:0000225) | 2.21692564 |
| 75 | Esophageal varix (HP:0002040) | 2.19066244 |
| 76 | Malnutrition (HP:0004395) | 2.18700105 |
| 77 | Pancreatitis (HP:0001733) | 2.14605469 |
| 78 | Menorrhagia (HP:0000132) | 2.14139786 |
| 79 | Enlarged kidneys (HP:0000105) | 2.13430878 |
| 80 | Late onset (HP:0003584) | 2.12957638 |
| 81 | Brushfield spots (HP:0001088) | 2.12895994 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.11524863 |
| 83 | Thrombophlebitis (HP:0004418) | 2.08444786 |
| 84 | Gangrene (HP:0100758) | 2.08105514 |
| 85 | Reduced antithrombin III activity (HP:0001976) | 2.06795218 |
| 86 | Vomiting (HP:0002013) | 2.06691270 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02920633 |
| 88 | Arthropathy (HP:0003040) | 2.02666792 |
| 89 | Opisthotonus (HP:0002179) | 2.01347089 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.00699464 |
| 91 | Abnormality of the gallbladder (HP:0005264) | 2.00033271 |
| 92 | Poikilocytosis (HP:0004447) | 1.97912990 |
| 93 | Hemorrhage of the eye (HP:0011885) | 1.95360862 |
| 94 | Generalized hypopigmentation of hair (HP:0011358) | 1.93911370 |
| 95 | Rickets (HP:0002748) | 1.92252896 |
| 96 | Alkalosis (HP:0001948) | 1.90475593 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 1.90193931 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 1.89653737 |
| 99 | Joint swelling (HP:0001386) | 1.89456892 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86534245 |
| 101 | Cerebral palsy (HP:0100021) | 1.85190612 |
| 102 | Renal cortical cysts (HP:0000803) | 1.84428215 |
| 103 | Hypophosphatemic rickets (HP:0004912) | 1.83451662 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 1.82958097 |
| 105 | Hydroxyprolinuria (HP:0003080) | 1.82958097 |
| 106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82099077 |
| 107 | Elevated alkaline phosphatase (HP:0003155) | 1.82005467 |
| 108 | Hyperglycemia (HP:0003074) | 1.81607389 |
| 109 | Elevated hepatic transaminases (HP:0002910) | 1.81408199 |
| 110 | Status epilepticus (HP:0002133) | 1.81314822 |
| 111 | Hyperphosphaturia (HP:0003109) | 1.79108631 |
| 112 | Abnormality of urine glucose concentration (HP:0011016) | 1.77418513 |
| 113 | Glycosuria (HP:0003076) | 1.77418513 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.75037956 |
| 115 | Nephritis (HP:0000123) | 1.74359261 |
| 116 | Atrioventricular block (HP:0001678) | 1.72627791 |
| 117 | Increased mean platelet volume (HP:0011877) | 1.71527985 |
| 118 | Epistaxis (HP:0000421) | 1.71461576 |
| 119 | Increased serum ferritin (HP:0003281) | 1.68099047 |
| 120 | Abnormality of the Achilles tendon (HP:0005109) | 1.67701426 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.66119626 |
| 122 | Bile duct proliferation (HP:0001408) | 1.58032777 |
| 123 | Abnormal biliary tract physiology (HP:0012439) | 1.58032777 |
| 124 | Blue irides (HP:0000635) | 1.57711236 |
| 125 | Facial shape deformation (HP:0011334) | 1.56473246 |
| 126 | Potter facies (HP:0002009) | 1.56473246 |
| 127 | Bifid scrotum (HP:0000048) | 1.55720960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.13672513 |
| 2 | FGFR4 | 4.63699381 |
| 3 | SIK1 | 4.52969895 |
| 4 | ERN1 | 4.52912871 |
| 5 | TAOK3 | 3.15642728 |
| 6 | INSRR | 3.10869820 |
| 7 | ERBB4 | 3.08837823 |
| 8 | NLK | 2.88455146 |
| 9 | STK38 | 2.51375617 |
| 10 | MAP2K4 | 2.36061514 |
| 11 | ACVR1B | 2.16230243 |
| 12 | PKN2 | 2.15250236 |
| 13 | MST1R | 2.08396709 |
| 14 | MAPK11 | 1.92087641 |
| 15 | FLT3 | 1.89476172 |
| 16 | PIK3CG | 1.76674082 |
| 17 | TRIB3 | 1.75017313 |
| 18 | LATS1 | 1.68276355 |
| 19 | TYK2 | 1.65720273 |
| 20 | ABL2 | 1.52455115 |
| 21 | ZAK | 1.48280061 |
| 22 | FRK | 1.48219999 |
| 23 | PTK6 | 1.45109305 |
| 24 | DAPK2 | 1.44045901 |
| 25 | NEK9 | 1.41392030 |
| 26 | FGFR2 | 1.40062291 |
| 27 | TNK2 | 1.39192977 |
| 28 | NTRK3 | 1.37422525 |
| 29 | JAK2 | 1.24371141 |
| 30 | KDR | 1.24197780 |
| 31 | BMPR1B | 1.18635164 |
| 32 | MAP3K7 | 1.18624867 |
| 33 | PRKAA2 | 1.15066761 |
| 34 | PINK1 | 1.14457985 |
| 35 | MAP3K2 | 1.11468353 |
| 36 | ERBB2 | 1.08309818 |
| 37 | MELK | 1.06519276 |
| 38 | GRK6 | 1.04229389 |
| 39 | TBK1 | 1.03139688 |
| 40 | FER | 1.02972088 |
| 41 | MAP2K3 | 1.02612110 |
| 42 | JAK1 | 1.02519733 |
| 43 | MAPK4 | 0.98828506 |
| 44 | MAP3K14 | 0.95631670 |
| 45 | MAPK15 | 0.94280348 |
| 46 | MAP3K10 | 0.92782739 |
| 47 | PRKCZ | 0.92308619 |
| 48 | STK38L | 0.86739443 |
| 49 | WNK3 | 0.86198130 |
| 50 | EPHA3 | 0.86028591 |
| 51 | EPHB1 | 0.85485485 |
| 52 | MET | 0.84944070 |
| 53 | MAP3K3 | 0.84433151 |
| 54 | PRKD3 | 0.80277497 |
| 55 | MAPK12 | 0.79490892 |
| 56 | CDK6 | 0.77470867 |
| 57 | PRKACA | 0.77221253 |
| 58 | PRKACG | 0.76815818 |
| 59 | CAMK2G | 0.75884997 |
| 60 | KSR2 | 0.75448696 |
| 61 | PRKG1 | 0.75433133 |
| 62 | ADRBK2 | 0.72526801 |
| 63 | MAP3K11 | 0.71340108 |
| 64 | STK3 | 0.70934237 |
| 65 | CAMKK2 | 0.70896635 |
| 66 | MAP2K6 | 0.69966193 |
| 67 | TIE1 | 0.68744452 |
| 68 | IRAK3 | 0.68376113 |
| 69 | PRKAA1 | 0.68362653 |
| 70 | CSK | 0.68048720 |
| 71 | DYRK1B | 0.68010991 |
| 72 | GSK3A | 0.67589078 |
| 73 | SGK3 | 0.66822963 |
| 74 | CAMK1D | 0.66354716 |
| 75 | PRPF4B | 0.65154463 |
| 76 | PDK2 | 0.61792736 |
| 77 | MAPK7 | 0.59718507 |
| 78 | FGFR3 | 0.59478721 |
| 79 | PTK2 | 0.55044066 |
| 80 | CSNK1D | 0.54926315 |
| 81 | CSF1R | 0.54067283 |
| 82 | RIPK1 | 0.54015297 |
| 83 | MYLK | 0.53082023 |
| 84 | GRK7 | 0.52987916 |
| 85 | IKBKE | 0.52889921 |
| 86 | CSNK1G1 | 0.52886547 |
| 87 | TGFBR2 | 0.50721373 |
| 88 | PDPK1 | 0.50336288 |
| 89 | PRKCQ | 0.48782881 |
| 90 | SGK2 | 0.48771122 |
| 91 | EPHA4 | 0.47153998 |
| 92 | MAP3K5 | 0.45556802 |
| 93 | IGF1R | 0.44277643 |
| 94 | TAOK2 | 0.43245900 |
| 95 | PKN1 | 0.43006956 |
| 96 | MAP2K1 | 0.42896376 |
| 97 | GRK1 | 0.42358095 |
| 98 | MAP3K13 | 0.41622105 |
| 99 | PRKCG | 0.41339752 |
| 100 | RET | 0.41131463 |
| 101 | PRKD1 | 0.39900338 |
| 102 | PRKCB | 0.39771863 |
| 103 | SGK1 | 0.39316290 |
| 104 | CDK4 | 0.38626977 |
| 105 | ADRBK1 | 0.38550044 |
| 106 | RPS6KA3 | 0.38053116 |
| 107 | PRKACB | 0.37966211 |
| 108 | MTOR | 0.37344184 |
| 109 | ICK | 0.37302795 |
| 110 | MAP3K6 | 0.37110202 |
| 111 | CAMKK1 | 0.34526994 |
| 112 | MAPKAPK3 | 0.33791583 |
| 113 | STK11 | 0.33694596 |
| 114 | EGFR | 0.33271477 |
| 115 | MAPK3 | 0.32833805 |
| 116 | CSNK1G2 | 0.32548594 |
| 117 | SGK223 | 0.32221072 |
| 118 | SGK494 | 0.32221072 |
| 119 | PBK | 0.32058795 |
| 120 | IRAK1 | 0.31329818 |
| 121 | CSNK1G3 | 0.29835111 |
| 122 | PDK1 | 0.29662773 |
| 123 | CAMK4 | 0.29658206 |
| 124 | WNK4 | 0.29565772 |
| 125 | MAP3K1 | 0.29386203 |
| 126 | CSNK1A1 | 0.28559672 |
| 127 | LATS2 | 0.27863736 |
| 128 | IRAK2 | 0.27455257 |
| 129 | MAP4K2 | 0.25903538 |
| 130 | PRKCA | 0.25869426 |
| 131 | CSNK1E | 0.25405755 |
| 132 | TLK1 | 0.23372874 |
| 133 | PRKCE | 0.22947124 |
| 134 | AKT2 | 0.22639582 |
| 135 | ABL1 | 0.22246495 |
| 136 | CSNK2A1 | 0.22082907 |
| 137 | AKT3 | 0.21934912 |
| 138 | KIT | 0.21881526 |
| 139 | PIK3CA | 0.21735853 |
| 140 | MAP2K2 | 0.21687540 |
| 141 | CSNK1A1L | 0.21195047 |
| 142 | PDK3 | 0.20770523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.61716758 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.77040234 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38989999 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.23803296 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81766411 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73743330 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69321026 |
| 8 | * Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.67590667 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64164904 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62570235 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48705335 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39063514 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28087907 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15811109 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13601074 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09764854 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96188471 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96136237 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93457136 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93372834 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93018374 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88515134 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.83956705 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81861481 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81486824 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79647823 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79042024 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72336085 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71268143 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69771345 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63419504 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57805688 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54304655 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.50984097 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37030426 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36364194 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30937598 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30596021 |
| 39 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28671215 |
| 40 | * Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28540618 |
| 41 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27350387 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25447598 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22199595 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.21686535 |
| 45 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18999236 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16321577 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15056044 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07347926 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06042930 |
| 50 | * Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00017011 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99228374 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98082285 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97724276 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95060917 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94059527 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89412508 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87089857 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85327003 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81650717 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78702445 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71588854 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68346618 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64993478 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59400280 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53160815 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50255284 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46978990 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40742411 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.39758764 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.32933766 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26746180 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26597018 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25711468 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.24977270 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23725949 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22813594 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19877624 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18273814 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12324715 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.06058854 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04049035 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.03409614 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2504074 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2375134 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2337785 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2300826 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | -0.2279359 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2253146 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2089248 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1922238 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1894129 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | -0.1882833 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1777343 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1726361 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1717315 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1689641 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1666513 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1638237 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1624569 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1566381 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1519890 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1443460 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1377162 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1218600 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | -0.0888138 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0865456 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0842737 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0832537 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0651556 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0492388 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0468001 |

